Nationwide, Pragmatic, Direct-to-Patient Primary Aldosteronism Testing Program

原发性醛固酮增多症 医学 内科学 醛固酮 盐皮质激素受体 醛固酮增多症 继发性高血压 人口 肾病科 儿科 血压 环境卫生
作者
Jenifer M. Brown,Laura C Tsai,E Abel,Arnaldo Ferrebus,Anna Moore,Yvonne Niebuhr,Bassil Bacare,Brooke Honzel,Julia Milks,Kevin M. Foote,Andrew J. Newman,Wasita Warachit Parksook,Anand Vaidya
出处
期刊:Hypertension [Lippincott Williams & Wilkins]
被引量:3
标识
DOI:10.1161/hypertensionaha.125.24648
摘要

BACKGROUND: Primary aldosteronism, an endocrinopathy present in ≥10% to 25% of patients with hypertension, confers excess cardiovascular risk that can be mitigated with aldosterone-directed therapy. However, only 2% of eligible patients undergo guideline-recommended screening. This study aimed to bypass clinical inertia and identify people with primary aldosteronism using pragmatic, direct-to-patient testing. METHODS: Hypertensive adults were recruited via online platforms and underwent virtual consent and local phlebotomy. Using a standardized diagnostic algorithm, laboratory results with interpretations were communicated to patients and primary care providers. Follow-up was ascertained at 6 to 12 months. The primary outcome was the frequency of a positive test for primary aldosteronism. Secondary outcomes included follow-up primary aldosteronism testing and implementation of aldosterone-targeted therapies. RESULTS: The study population (N=694) had a mean age of 63.3±11.3 years, was 52.2% female, and hailed from 41 US states. Overall, 25.4% had a positive test for primary aldosteronism. Sleep apnea, resistant hypertension, and hypokalemia were the most common testing indications, with 55.2% of participants having ≥2 indications. Over half of participants (57%) were already under endocrinology, cardiology, or nephrology care, yet had not been tested. In longitudinal follow-up of participants with a positive result, 25.5% had additional testing and 13.7% were started on aldosterone-targeted therapy (mineralocorticoid receptor antagonist or adrenalectomy). CONCLUSIONS: Pragmatic, direct-to-patient testing, and simplified results interpretation is a feasible, scalable method to increase primary aldosteronism diagnoses and implementation of aldosterone-targeted therapies. Given that new hypertension guidelines recommend primary aldosteronism screening in all hypertensive people, practical approaches to test, interpret, and implement results will be essential.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaozaix发布了新的文献求助10
刚刚
伟伟完成签到,获得积分10
1秒前
blueblue完成签到,获得积分10
1秒前
2秒前
3秒前
lilian发布了新的文献求助10
3秒前
妩媚完成签到,获得积分10
4秒前
Abner完成签到,获得积分10
4秒前
4秒前
长情天川完成签到,获得积分10
4秒前
乐观蚂蚁发布了新的文献求助10
4秒前
仁爱帆布鞋完成签到,获得积分10
5秒前
5秒前
JTB发布了新的文献求助10
5秒前
无极微光应助皮皮硕桑采纳,获得20
7秒前
晴天娃娃完成签到,获得积分10
7秒前
7秒前
徐菁完成签到,获得积分10
7秒前
李健的粉丝团团长应助ygh采纳,获得10
7秒前
8秒前
8秒前
KKXX51129完成签到,获得积分10
9秒前
guozi发布了新的文献求助20
9秒前
fhn716完成签到,获得积分10
9秒前
9秒前
hsy完成签到,获得积分10
10秒前
10秒前
晴天娃娃发布了新的文献求助10
10秒前
Meena完成签到 ,获得积分10
10秒前
宇文书翠发布了新的文献求助10
11秒前
112450195完成签到,获得积分10
11秒前
张强完成签到,获得积分10
11秒前
充电宝应助linlin采纳,获得10
12秒前
13秒前
ningzi发布了新的文献求助10
13秒前
潇洒的惋清应助wjpwjp123采纳,获得10
13秒前
仁爱听露完成签到 ,获得积分10
14秒前
法瓷双厨完成签到,获得积分10
14秒前
勤恳的向日葵完成签到,获得积分10
14秒前
咚咚发布了新的文献求助20
15秒前
高分求助中
Clinical Epidemiology: The Essentials, 6e 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6536448
求助须知:如何正确求助?哪些是违规求助? 8329348
关于积分的说明 17846431
捐赠科研通 5638850
什么是DOI,文献DOI怎么找? 2935146
邀请新用户注册赠送积分活动 1911321
关于科研通互助平台的介绍 1769995